Predicting fetal growth restriction in high-risk pregnancies
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study aims to better predict fetal growth restriction (when a baby doesn't grow as expected) in women who have certain risk factors. By joining, you may help doctors develop better screening tools for future pregnancies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and less than 14 weeks along.
- You are between 18 and 45 years old.
- You have at least one major risk factor, such as being over 40, having had a previous pregnancy with growth restriction or preeclampsia, or having a chronic condition like high blood pressure or diabetes.
- Or you have at least two minor risk factors, such as being 35–40, having a BMI over 28 (or under 18.5), conceiving with fertility treatment, or having a long or short gap since your last baby.
- Your baby must not have known genetic or severe structural problems found on ultrasound or genetic testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how early, slow fetal growth is managed during pregnancy. It compares an “angiogenic factors” approach with an ultrasound (blood-flow) approach to help guide care and improve outcomes.
This study looks at babies in monochorionic (shared-placenta) twin pregnancies where one or both babies are growing too slowly. It aims to better understand this condition and follow families over time to improve care, with check-ins through age 2 after birth.
This trial compares a new method (STV analysis) to the usual visual check of baby heart rate recordings (CTG) for pregnant people with severe early-onset fetal growth restriction. It aims to see if the new method helps doctors make better decisions about monitoring and delivery timing.
This study looks at therapies meant to support brain development in babies whose growth is slower than expected before birth. It enrolls pregnancies in a specific time window and uses ultrasound/Doppler testing to make sure the baby is not likely needing delivery immediately.
This study follows women whose babies have a growth problem in the womb (FGR) linked to how blood flows to the placenta. It looks at causes and outcomes to help improve care.
This study uses artificial intelligence (AI) to analyze ultrasound images and predict pregnancy outcomes for babies with early-onset fetal growth restriction (FGR) caused by placenta problems. If you are carrying a single baby with this condition and your doctor is continuing to monitor the pregnancy without immediate delivery, this trial may apply to you.
Hear when a new Fetal Growth Retardation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.